Influence of CYP3A4-induction by St. John's Wort (SJW) on the Steady State Pharmacokinetics of Ambrisentan.
Phase of Trial: Phase IV
Latest Information Update: 05 Jun 2017
At a glance
- Drugs Hypericum (Primary) ; Ambrisentan
- Indications Depression
- Focus Pharmacokinetics
- 01 Dec 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 15 Mar 2011 New trial record